.Given Imaging Ltd., the maker of a capsule-sized camera for diagnosing digestive ailments, climbed to the highest in more than two months as the U.S. Food and Drug Administration, or FDA, cleared use of its monitoring system.
The shares of Yoqneam, Israel-based Given rose 2.1 percent to 60.97 shekels, the highest intraday level since Nov. 4, as of 3:01 p.m. in Tel Aviv.
The FDA today cleared use of Given’s Bravo pH system in patients four years of age and older, allowing physicians to measure gastroesophageal pH and monitor gastric reflux, the company said in a Marketwire statement.
To contact the reporter on this story: David Wainer in Tel Aviv at firstname.lastname@example.org
To contact the editor responsible for this story: Claudia Maedler at email@example.com .
One by one GIVN keeps patiently working and getting FDA approvals for new indications with its PillCam. One day the PillCam will be FDA approved for just about anything pertaining to the gastrointestinal tract. Today yet another FDA approval for the PillCam.